10:23 AM EDT, 07/03/2024 (MT Newswires) -- Scinai Immunotherapeutics ( SCNI ) said Wednesday that Nasdaq has granted its request for an extension through Aug. 14 to regain compliance with the exchange's continued listing requirements.

On or before Aug. 14, Scinai said it must file a public disclosure showing compliance with the requirement that companies listed on the exchange maintain stockholders' equity of at least $2.5 million.

Price: 3.01, Change: -0.04, Percent Change: -1.31